LEMAITRE VASCULAR INC — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2019-12-19

Reporting Person: Pellegrino Joseph P JR (Director, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-19	Common Stock	M	5	—	Acquired	31054	Direct
2019-12-19	Common Stock	F	238	$35.83	Disposed	30816	Direct
2019-12-19	Common Stock	S	2785	$36.0491	Disposed	28264	Direct
2019-12-20	Common Stock	A	1762	—	Acquired	30026	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-19	Dividend Equivalent Rights	$	M	5	Disposed		Common Stock (5)	Direct
2019-12-20	Stock Option (Right to Buy)	$35.48	A	14706	Acquired	2026-12-20	Common Stock (14706)	Direct

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F3: This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.

F4: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

F5: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

F6: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.